University of Washington
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Washington sits in the top decile of US sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count).
University of Washington: 1,048 sponsored US clinical trials, 156 recruiting.
University of Washington sponsors 1,048 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 720 completed. 104 of these trials are in Phase 3-4 (later-stage) and 320 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 13 trials.
Top-decile sponsor footprint
University of Washington ranks in the top decile of sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
720 of 816 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,048 total, page 17 of 21
TakeCharge: Telephone Delivered Self-management Intervention for People With Multiple Sclerosis (MS)
NCT00944190
Metabolic Effects of Paricalcitol
NCT01003275
Single Dose Monurol for Treatment of Acute Cystitis
NCT00976963
The Men's Domestic Abuse Check-Up Engages Adult Men Concerned About Their Abusive Behavior and Alcohol or Drug Use
NCT01621334
Enhancing Extinction Learning in Post Traumatic Stress Disorder (PTSD)
NCT01188694
Telephone Intervention for Pain Study (TIPS)
NCT00663663
Study of the Safety and Efficacy of Conivaptan (Vaprisol®) to Raise Serum Sodium Levels in Patients With Severe Traumatic Brain Injury
NCT00930202
Treating PTSD in Patients With Borderline Personality Disorder
NCT01081314
Patient and Partner Intervention After an Implantable Cardioverter Defibrillator (ICD)
NCT01252615
Neurofeedback Treatment of Pain in Persons With Spinal Cord Injury (SCI)
NCT00947999
Hormone and Information Processing Study
NCT00539305
Oral T7 Oral Testosterone in Man
NCT00842751
Outcomes Associated With Application of a Normothermia Protocol in Patients With Severe Neurological Insult and Fever
NCT00890604
Vorinostat in Patients With Primary Cutaneous T-Cell Lymphoma
NCT00958074
Effect of Diet Composition on Liver Fat and Glucose Metabolism
NCT00930371
Staying Connected: Trauma Center to Tribal Community Linkage for Physically Injured American Indian Patients
NCT00938067
Brief Intervention in Primary Care for Problem Drug Use and Abuse
NCT00877331
Safety Study of Cervical Sympathetic Block for Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage
NCT00930072
Nursing Management of Irritable Bowel Syndrome (IBS) 2008
NCT00907790
HOP-3 Manipulation of the Intratesticular Hormonal Milieu With Exogenous Testosterone
NCT00839319
Immunologic Effects of Echinacea
NCT00860795
Peripheral Immunologic Response of Solid Organ Transplant Recipients to Depletion Versus Non-depletion Protocols
NCT00839709
Educational Counseling in Improving Communication and Quality of Life in Spouses and Breast Cancer Patients
NCT01723943
Homeopathic Cold Medicine for Children
NCT00858494
Raltegravir (Isentress/MK-0518) and HIV-1 Infected CD4 Cells During Acute/Early HIV-1
NCT00781287
Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation Therapy
NCT00895245
Clofarabine and Cytarabine in Treating Patients With Acute Myeloid Leukemia With Minimal Residual Disease
NCT00863434
Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver Transplant
NCT00844168
Cognitive Behavioral Therapy for Arthritis Pain and Insomnia in Older Adults
NCT01142349
PROS-1-Male Hormonal Contraceptive Regimens on Prostate Tissue
NCT00490555
Early Intervention in Pulmonary Exacerbation in Cystic Fibrosis
NCT00850551
Sinusitis and Facial Pain Disorders Anti-Depression Trial
NCT00754793
Topical Imiquimod and Abraxane in Treating Patients With Advanced Breast Cancer
NCT00821964
Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2
NCT01346475
Assessment of Socket Shapes Made by Central Fabrication Facilities
NCT01245504
Pegylated Liposomal Doxorubicin Hydrochloride, Bortezomib, Cyclophosphamide, and Dexamethasone in Treating Patients With Multiple Myeloma
NCT00849251
Mindful Awareness in Body-Oriented Therapy for Women's Substance Abuse Treatment
NCT01280916
ORAL T-6: Oral Androgens in Man-6
NCT00663793
Vaccine Therapy in Treating Patients With Stage IV Breast Cancer
NCT00791037
Study of Effectiveness of IMC-A12 Antibody Combined With Hormone Therapy Prior to Surgery to Treat Prostate Cancer
NCT00769795
Improving Oral Health With Serious Games
NCT02027597
Bendamustine Hydrochloride in Treating Patients With Recurrent or Progressive Anaplastic Glioma
NCT00823797
Disseminating Organizational SBI Services at Trauma Centers
NCT00607620
Two-Point Measurement of Glomerular Filtration Rate by Iohexol Plasma Disappearance
NCT01545531
HOP-2A - Intratesticular Hormone Levels
NCT00756561
Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver Cancer
NCT00787787
A Randomized Trial to Evaluated the Suppressive Effect of Acyclovir on Rapidly Cleared HSV-2 Reactivation
NCT00723229
Effect of Diesel Exhaust Particulate Exposures on Endothelial Function in Humans
NCT00434005
Depression and ART Adherence in HIV+ Latinos
NCT01411839
Validating PROMIS Instruments in Back and Leg Pain
NCT00784251
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 127 |
| Phase 2 | 193 |
| Phase 3 | 39 |
| Phase 4 | 65 |
What is open in the University of Washington pipeline
156 recruiting of 1,048 indexed (15% open); 720 completed (69%).
Phase mix: 104 late (III/IV) vs 320 early (I/II) (early-phase heavy).
Top condition: Depression (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Washington: open-pipeline peers nationwide
Peers matched on 1,048 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Washington sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,048 trials (± recruiting share)
- University of Wisconsin, Madison · 1,039 trials · 15% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
- University of Florida · 1,106 trials · 15% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Dompé Farmaceutici S.p.A · 15% recruiting · 27 trials
- Vanderbilt-Ingram Cancer Center · 15% recruiting · 189 trials
- Arizona State University · 15% recruiting · 187 trials
- Georgetown University · 15% recruiting · 227 trials
Related
What to do with this University of Washington page
1,048 registered trials is a research-attention snapshot, not an endorsement of University of Washington or any single study.
- 156 of University of Washington's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Washington studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Washington pipeline card: 1,048 registered trials from official public datasets.Report a data error.